Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 28:15:2289-2295.
doi: 10.2147/COPD.S264889. eCollection 2020.

Higher Blood Vascular Cell Adhesion Molecule-1 is Related to the Increased Risk of Cardiovascular Events in Chronic Obstructive Pulmonary Disease

Jinlin Li  1 , Qi Wang  1 , Qingping Zhang  2 , Zhengyan Wang  1 , Xin Wan  3 , Chenfang Miao  4 , Xi Zeng  5
Affiliations

Higher Blood Vascular Cell Adhesion Molecule-1 is Related to the Increased Risk of Cardiovascular Events in Chronic Obstructive Pulmonary Disease

Jinlin Li et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Background: Vascular cell adhesion molecule-1 (VCAM-1) is associated with vascular-related inflammation and atherosclerosis. This study aimed to evaluate whether VCAM-1 can be used for an indication of increased risk of CV events in patients with COPD.

Methods: Serum VCAM-1 levels were measured in 163 COPD patients. All COPD patients were prospectively followed up for a median period of 48 months (range=3-54). Cox proportional hazard analysis was performed to evaluate the prognostic value of serum VCAM-1 for predicting CV events.

Results: Serum VCAM-1 levels were higher in COPD patients with CV events than in those without CV events (1174.4±365.3 ng/mL vs 947.8±293.2 ng/mL; P<0.001). The logistic regression analysis revealed that serum VCAM-1 (OR=1.750; 95% CI, 1.324-2.428; Ptrend=0.0012) was independently associated with CVD (cardiovascular disease) history after adjusting for age, sex, BMI, current smoker, current drinker, admission systolic and diastolic BP, LVEF and laboratory measurements in patients with COPD at baseline. The Kaplan-Meier analysis demonstrated that the rate of CV events was higher in COPD patients with serum VCAM-1 levels above the median (517.3 ng/mL) than in those with VCAM-1 levels below the median. The Cox proportional hazard analysis revealed that serum VCAM-1 (HR=2.617; 95% CI, 1.673-5.328; Ptrend<0.001) may be an independent prognostic factor for CV events in the COPD patients.

Conclusion: Our results suggested that serum VCAM-1 was significantly and independently associated with CV events in COPD patients. The inflammatory marker may help clinicians predict CV complications early.

Keywords: cardiovascular events; chronic obstructive pulmonary disease; prognostic value; vascular cell adhesion molecule-1.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Kaplan–Meier analysis of cardiovascular (CV) events free stratified into 2 groups by the median levels of serum vascular cell adhesion molecule-1 (VCAM-1).
See this image and copyright information in PMC

References

    1. Yang IA, Brown JL, Johnson G, et al. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update. Medical J Australia. 2017;207(10):436–442. doi:10.5694/mja17.00686 - DOI - PubMed
    1. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. - PubMed
    1. Leitao FF, Sin DD. COPD and cardiovascular diseases: now is the time for action. Thorax. 2018;73(9):799–800. doi:10.1136/thoraxjnl-2018-211553 - DOI - PubMed
    1. Schneider C, Bothner U, S S J, et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253–260. doi:10.1007/s10654-010-9435-7 - DOI - PubMed
    1. Barnes PJ. Senescence in COPD and its Comorbidities. Annu Rev Physiol. 2017;79(1):517. doi:10.1146/annurev-physiol-022516-034314 - DOI - PubMed

MeSH terms

Substances